Literature DB >> 7615761

Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.

P Le Cann1, A Touze, N Enogat, D Leboulleux, C Mougin, M C Legrand, C Calvet, J M Afoutou, P Coursaget.   

Abstract

The L1 major capsid protein of human papillomavirus type 16 (HPV-16) was expressed in Sf-21 insect cells with a recombinant baculovirus. Virus-like particles obtained were purified and used to develop an enzyme-linked immunosorbent assay for detection of anti-HPV-16 antibodies in sera from 76 women with evidence of genital HPV infection and 79 controls. HPV-16-infected individuals developed antibodies directed at HPV-16 virions since reactivity against recombinant HPV-16L1 capsids was observed in 50% of them compared with only 6% in the general adult population. However, some cross-reactivities with sera from women infected with others HPV types were observed.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7615761      PMCID： PMC228172          DOI： 10.1128/jcm.33.5.1380-1382.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1.

Authors:  J C Steele; P H Gallimore
Journal:  Virology       Date:  1990-02       Impact factor: 3.616

2.  Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11.

Authors:  N D Christensen; J W Kreider; N M Cladel; S D Patrick; P A Welsh
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  Antibody-mediated neutralization in vivo of infectious papillomaviruses.

Authors:  N D Christensen; J W Kreider
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses.

Authors:  L Dillner; P Heino; J Moreno-Lopez; J Dillner
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus.

Authors:  C S McLean; M J Churcher; J Meinke; G L Smith; G Higgins; M Stanley; A C Minson
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

6.  Prevalence of antibodies to human papillomavirus type 8 in human sera.

Authors:  G Steger; M Olszewsky; E Stockfleth; H Pfister
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

Authors:  R Kirnbauer; F Booy; N Cheng; D R Lowy; J T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Antibodies to human papillomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products.

Authors:  H G Köchel; K Sievert; M Monazahian; A Mittelstädt-Deterding; A Teichmann; R Thomssen
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

9.  Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.

Authors:  R C Rose; W Bonnez; R C Reichman; R L Garcea
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Antibody response to human papillomavirus (HPV) type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP).

Authors:  W Bonnez; H K Kashima; B Leventhal; P Mounts; R C Rose; R C Reichman; K V Shah
Journal:  Virology       Date:  1992-05       Impact factor: 3.616
View more
  11 in total

1.  In vitro gene transfer using human papillomavirus-like particles.

Authors:  A Touze; P Coursaget
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

2.  Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes.

Authors:  A Touzé; S de Sanjosé; P Coursaget; M R Almirall; V Palacio; C J Meijer; J Kornegay; F X Bosch
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus.

Authors:  Yevgeniy Y Studentsov; Mark Schiffman; Howard D Strickler; Gloria Y F Ho; Yuk-Ying Susana Pang; John Schiller; Rolando Herrero; Robert D Burk
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

4.  Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.

Authors:  T Sasagawa; M Inoue; M Lehtinen; W Zhang; S E Gschmeissner; M A Hajibagheri; J Finch; L Crawford
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

5.  Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients.

Authors:  Hala Badawi; Hanem Ahmed; Ahmed Ismail; Manal Diab; Magd Moubarak; Afkar Badawy; Mohamed Saber
Journal:  Medscape J Med       Date:  2008-10-08

Review 6.  Immunomanipulative strategies for the control of human papillomavirus associated cervical disease.

Authors:  R W Tindle
Journal:  Immunol Res       Date:  1997       Impact factor: 4.505

7.  Antibodies to human papillomavirus 16, 18, 58, and 6b major capsid proteins among Japanese females.

Authors:  K Matsumoto; H Yoshikawa; Y Taketani; K Yoshiike; T Kanda
Journal:  Jpn J Cancer Res       Date:  1997-04

8.  Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica.

Authors:  S S Wang; M Schiffman; T S Shields; R Herrero; A Hildesheim; M C Bratti; M E Sherman; A C Rodriguez; P E Castle; J Morales; M Alfaro; T Wright; S Chen; B Clayman; R D Burk; R P Viscidi
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

9.  The epidemiology of conjunctival squamous cell carcinoma in Uganda.

Authors:  R Newton; J Ziegler; C Ateenyi-Agaba; L Bousarghin; D Casabonne; V Beral; E Mbidde; L Carpenter; G Reeves; D M Parkin; H Wabinga; S Mbulaiteye; H Jaffe; D Bourboulia; C Boshoff; A Touzé; P Coursaget
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

10.  Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica.

Authors:  S S Wang; M Schiffman; R Herrero; J Carreon; A Hildesheim; A C Rodriguez; M C Bratti; M E Sherman; J Morales; D Guillen; M Alfaro; B Clayman; R D Burk; R P Viscidi
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.